Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects receiving NUCALA for the first time for treatment of bronchial asthma (a refractory asthma whose symptoms are inadequately controlled despite receiving standard asthma medications)
Clareo Health | Long Term Special Drug Use Investigation of Mepolizumab
